Quinine, 4-aminopyridine and tetraethylammonium, three compounds generally used as effectors of K+ channels, strongly modify phospholipid metabolism. In the human monocytic cell line THPI, the three drugs enhanced the incorporation of [3H]serine into phosphatidylserine and that of [3H]inositol into phosphatidylinositol in the absence of significant changes in the uptake of the 3H labels. On the contrary, the biosynthesis of both phosphatidylcholine and phosphatidylethanolamine was strongly inhibited. This inhibition appeared to be mainly due to the inhibition of both [3H]choline and [3H]ethanolamine uptake by the cells, by impairment of choline transport in a competitive mode.
INTRODUCTION
Three compounds, quinine, 4-aminopyridine and tetraethylammonium, generally used as effectors of K+ channels, are able to increase phosphatidylserine synthesis in the human T-cell line Jurkat (Aussel et al., 1990a) . Changes in phosphatidylserine synthesis occurred in a range of concentrations similar to that used to block K+ channels, to inhibit interleukin-2 synthesis or to impair T-cell proliferation induced by lectins or monoclonal antibodies directed against the T-cell receptor complex. Phospholipid synthesis takes part in long-lasting biological events such as cell proliferation. In addition, it is well known that mammalian cells grown in culture have a nutritional requirement for one or more lipid precursors. Thus it was decided to study the effect on phospholipid synthesis of some drugs used to regulate cell proliferation through K+-channel blockade. Whether changes in phosphatidylserine induced by K+-channel blockers are specific to the Jurkat cell line and whether the synthesis of the other phospholipids is affected by these drugs remained unknown. In the present paper we show that, in the human monocytic cell line THP1, quinine, 4-aminopyridine and tetraethylammonium markedly increase phosphatidylserine and phosphatidylinositol synthesis and strongly decrease phosphatidylcholine and phosphatidylethanolamine synthesis.
MATERIALS AND METHODS Cells
The monocytic cell line THP1 was cultured in RPMI 1640 (Seromed, Lille, France) supplemented with 5 % (v/v) fetal-calf serum, 2 mM-L-glutamine and 1 mM-pyruvate.
Chemicals
Quinine, 4-aminopyridine and tetraethylammonium chloride were purchased from Aldrich Chimie (Strasbourg, France). Phospholipid synthesis THP1 cells (2 x 106) were maintained in 0.5 ml of buffer (pH 7.4) containing 137 mM-NaCl, 2.7 mM-KCl, 1 mMNa2HPO4, 2.5 mM-glucose, 20 mM-Hepes, 0.1 % BSA, 1 mMCaCl2 and 1 mM-MgCl2, at 37°C in the presence of the tritiated precursors for phospholipid synthesis and effectors (see concentrations in the Figure legends) . After an incubation period of 2-4 h, the cells were rapidly sedimented in an Eppendorf centrifuge, washed, the supernatants were discarded, and the cell phospholipids were extracted with chloroform/methanol/water (Bligh & Dyer, 1959) . This two-step extraction procedure allowed the determination of total 3H-labelled products incorporated into the cells, by measuring radioactivity in a 50 ,ul sample of the chloroform/methanol extract. Relationships between polar head-group incorporation and phospholipid synthesis In order to verify whether the changes observed in phospholipid metabolism are due to eventual modifications of the uptake of the different phospholipid polar head groups, we have measured the total incorporation of the four tritiated polar head groups by the cells and plotted this value versus the amount of phospholipid synthesized. As shown in Fig. 2 Fig. 2a) , 4-aminopyridine (Fig. 2b) or tetraethylammonium (Fig. 2c) .
Quinine, 4-aminopyridine and tetraethylammonium inhibit the uptake of choline and ethanolamine
The above data strongly suggested that both A concentration-dependent inhibition of [3H]choline (Fig. 3a) and [3H]ethanolamine (Fig. 3b) Fig. 4 , indicated that the drugs were competitive inhibitors of choline uptake. V,Kax. (5 + 0.2 ,amol/min per 106 cells for controls; n = 6) remained quite constant (less than 20 variation) in the presence of the drugs. In contrast, the apparent Km (8.5 /tM for control cells) was changed considerably. The values found were 15.4 /LM in the presence of quinine, 27.1 /tM in the presence of 4-aminopyridine and 20 ,uM in the presence of tetraethylammonium. Hemicholinium-3, a well-known competitive inhibitor of choline transport (Barker & Mittag, 1975; Ancelin & Vial, 1986; Sheff et al., 1990 Sheff et al., , 1991 , was included at 20,UM for comparison in several experiments; an apparent Km of 13.9 ,tM was found, with a Vmax of 4.95 ,umol/min per 106 cells.
Changes in phosphatidylserine and phosphatidylinositol synthesis are not correlated with the inhibition of choline incorporation Since the three drugs quinine, 4-aminopyridine and tetraethylammonium concomitantly inhibited phosphatidylethanolamine and phosphatidylcholine synthesis and enhanced phosphatidylserine and phosphatidylinositol synthesis, we tested whether a well-known competitive inhibitor of choline transport, hemicholinium-3 (Ancelin & Vial, 1986; Sheff et al., 1990) affected serine uptake or phosphatidylserine metabolism. As shown in Fig. 5(a) Kuo, 1985) . On the other hand, changes in the activity of K+ channels have been involved both in the regulation of cell metabolism as well as in the regulation of cell proliferation (Gardner, 1990; Gelfand, 1989; Gallin, 1986) . For example, in the immune system, the participation of K+ channels in the regulation of interleukin-2 synthesis and Tcell proliferation has been obtained from experiments demonstrating that the classical K+-channel blockers such as quinine, 4-aminopyridine and tetraethylammonium were able to block T-cell responses at concentrations similar to those generally used to block the K+ channel when studied by electrophysiological techniques (Grissmer & Cahalan, 1989; Cahalan et al., 1985) . Recently we showed (Aussel et al., 1990a) pyridine and tetraethylammonium, markedly change phospholipid metabolism in THP1 cells. The three drugs clearly inhibit both phosphatidylcholine and phosphatidylethanolamine synthesis (Fig. 1) . The mechanism of this inhibition involves a decreased uptake of the polar head group into the cells (Figs. 3  and 4) , since the drugs act as competitive inhibitors of choline transport. On the contrary, synthesis of both phosphatidylserine and phosphatidylinositol was increased without noticeable changes in the uptake of either serine or myo-inositol into the cells. Use of hemicholinium-3, a drug that is known as a competitive inhibitor of choline transport in various cell types (Ancelin & Vial, 1986; Sheff et al., 1990) , unambiguously demonstrated that inhibition ofboth choline uptake and phosphatidylcholine synthesis or ethanolamine uptake and ethanolamine synthesis remained without effect on the synthesis of the other phospholipids, phosphatidylserine and phosphatidylinositol. This indicates that the pathways leading to the synthesis of the different phospholipid classes are not directly correlated. In addition, and in contrast with our previous results obtained in Jurkat cells (Aussel et al., 1990b) , no incorporation of [3H]serine into phosphatidylethanolamine (through decarboxylation of phosphatidylserine) nor into phosphatidylcholine (through the transmethylation of phosphatidylethanolamine) could be demonstrated in THPI cells.
Changes in phosphatidylserine and/or phosphatidylinositol synthesis induced by quinine, 4-aminopyridine and tetraethylammonium may represent either a side effect of these drugs or an intermediary step between the blockade of K+ channels and longlasting biological responses such as protein synthesis and cell proliferation. Further work is necessary to elucidate the exact mechanism of regulation of phospholipid metabolism, and especially the regulation of the base-exchange enzyme system (that leads to the biosynthesis of phosphatidylserine), by these drugs and the eventual participation of K+ channels in this regulation. Interestingly, a recent paper (Smejtek et al., 1990) demonstrated that the potencies of aminopyridines in blocking K+ channels correlate with the association constants of the drugs with phosphatidylserine membranes. The possibility that aminopyridines act at the intracellular face of the K+ channel and that this binding domain has characteristics similar to that of the phosphatidylserine head group (Molgo et al., 1985) emphasize the relationships between K+ channels and phosphatidylserine.
